General MedicationsORALGeneric
INDAPAMIDE
INDAPAMIDE
Standard Dose
1.25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview INDAPAMIDE is listed in Drugs@FDA under application 075201 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient INDAPAMIDE Form and strength TABLET;ORAL - 1.25MG Sponsor ANI PHARMS Submission history Latest submission status date: 2023-10-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview INDAPAMIDE is listed in Drugs@FDA under application 075201 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient INDAPAMIDE Form and strength TABLET;ORAL - 1.25MG Sponsor ANI PHARMS Submission history Latest submission status date: 2023-10-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.